About
Seagen is a biotechnology company that develops and commercializes antibody-drug conjugates (ADCs) and other targeted therapies for the treatment of cancer.
Explore Seagen (formerly Seattle Genetics)'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.